March 24, 2011
A federal judge in California gave an initial green light Thursday to an $8.9 million settlement pact in a securities class action accusing pharmaceutical company Nuvelo Inc. of making misrepresentations about clinical trials for the blood clot dissolving drug alfimeprase.